Immunomodulatory, insulinotropic, and cytotoxic activities of phylloseptins and plasticin-TR from the Trinidanian leaf frog Phyllomedusa trinitatis.


Journal

Journal of peptide science : an official publication of the European Peptide Society
ISSN: 1099-1387
Titre abrégé: J Pept Sci
Pays: England
ID NLM: 9506309

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 24 11 2018
revised: 11 01 2019
accepted: 14 01 2019
pubmed: 9 2 2019
medline: 10 8 2019
entrez: 9 2 2019
Statut: ppublish

Résumé

The aim of the study was to determine the in vitro immunomodulatory, cytotoxic, and insulin-releasing activities of seven phylloseptin-TR peptides and plasticin-TR, first isolated from the frog Phyllomedusa trinitatis. The most cationic peptides, phylloseptin-1.1TR and phylloseptin-3.1TR, showed greatest cytotoxic potency against A549, MDA-MB231, and HT-29 human tumor-derived cells and against mouse erythrocytes. Phylloseptin-4TR was the most hydrophobic and the most effective peptide at inhibiting production of the proinflammatory cytokines TNF-α and IL-1β by mouse peritoneal cells but was without effect on production of the antiinflammatory cytokine IL-10. Phylloseptin-2.1TR and phylloseptin-3.3TR were the most effective at stimulating the production of IL-10. The noncytotoxic peptide, plasticin-TR, inhibited production of TNF-α and IL-1β but was without effect on IL-10 production. The results of CD spectroscopy suggest that the different properties of plasticin-TR compared with the immunostimulatory activities of the previously characterized plasticin-L1 from Leptodactylus laticeps may arise from greater ability of plasticin-TR to oligomerize and adopt a stable helical conformation in a membrane-mimetic environment. All peptides stimulated release of insulin from BRIN-BD11 rat clonal β cells with phylloseptin-3.2TR being the most potent and effective and phylloseptin-2.1TR the least effective suggesting that insulinotropic potency correlates inversely with helicity. The study has provided insight into structure-activity relationships among the phylloseptins. The combination of immunomodulatory and insulinotropic activities together with low cytotoxicity suggests that phylloseptin-3.3TR and plasticin-TR may represent templates for the development of agents for use in antiinflammatory and type 2 diabetes therapies.

Identifiants

pubmed: 30734396
doi: 10.1002/psc.3153
doi:

Substances chimiques

Anti-Inflammatory Agents 0
Antimicrobial Cationic Peptides 0
Cytotoxins 0
Eye Proteins 0
Insulin 0
Nerve Tissue Proteins 0
plasticin 148996-63-8

Types de publication

Journal Article

Langues

eng

Pagination

e3153

Subventions

Organisme : Ministry of Education, Science and Technological Development, Serbia
ID : ON 175103
Organisme : Ministry of Education, Science and Technological Development, Serbia
ID : ON 175071
Organisme : Ministry of Education, Science and Technological Development, Serbia
ID : ON 175069
Organisme : University of the West Indies Campus Research and Publication Fund
ID : #26600-457118
Organisme : Labex Synorg
ID : ANR-11-LABX-0029
Organisme : Ulster University Strategic Funding
Organisme : Northern Ireland Department of Education and Learning (DEL)

Informations de copyright

© 2019 European Peptide Society and John Wiley & Sons, Ltd.

Auteurs

Jelena Pantic (J)

Center for Molecular Medicine and Stem Cell Research, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.

Laure Guilhaudis (L)

Normandy University, COBRA, UMR 6014 & FR 3038, Université de Rouen, INSA, Rouen, France.

Vishal Musale (V)

Diabetes Research Group, School of Biomedical Sciences, Ulster University, Coleraine, UK.

Samir Attoub (S)

Department of Pharmacology, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, United Arab Emirates.

Miodrag L Lukic (ML)

Center for Molecular Medicine and Stem Cell Research, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.

Milena Mechkarska (M)

Department of Life Sciences, The University of the West Indies, St. Augustine, Trinidad and Tobago.

J Michael Conlon (JM)

Diabetes Research Group, School of Biomedical Sciences, Ulster University, Coleraine, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH